Doctors treat deep brain tumor with novel MRI-guided laser technology

February 25, 2014 by Jackie Carr, University of California - San Diego
With MRI guidance, Chen can safely destroy tumors seated deep in the patient’s brain.

Using a novel magnetic resonance imaging (MRI)-guided laser technology, neurosurgeons at UC San Diego Health System have successfully treated a malignant tumor deep inside a patient's brain. This is the first time that this FDA-approved laser-based treatment has been performed in California.

"The patient's brain was located in the thalamus. Normally, to access a tumor in this region, the surgeon would have to remove considerable healthy , thus subjecting the patient to significant neurologic injury," said neurosurgeon Clark C. Chen, MD, PhD, vice chairman of research, UC San Diego Division of Neurosurgery. "This MRI-guided laser technology helps neurosurgeons preserve healthy brain tissues while allowing treatment of tumors that would otherwise be inoperable."

Chen and his team used a technique called laser interstitial thermal therapy. The procedure is performed inside an MRI machine while the patient is under general anesthesia. A dime-size hole is created in the patient's skull to access the tumor. A laser probe is then inserted into the tumor under real-time MRI monitoring and computer guidance. When the tumor is reached, the laser beam is activated, heating and destroying .

Doctors treat deep brain tumor with novel MRI-guided laser technology
Neurosurgeon Clark Chen, MD, PhD, treats recurrent brain cancer with MRI-guided laser technology at UC San Diego Health System.

"It is well-known that MRI can be used to generate detailed images of the brain. What is less known is that MRI can also be used to measure the internal temperature of the brain," said Chen. "With this application, I can view the tumor in real time as it is being destroyed while customizing the effects of the laser to the tumor without injuries to the surrounding normal brain. This incredible visualization allows neurosurgeons to preserve billions of neuronal connections that are essential for normal brain function."

Many types of can be treated using this , according to Chen, including glioblastomas, anaplastic astrocytomas and brain metastases. A comprehensive risk-benefit analysis is conducted for each patient to determine if a minimally invasive or open-approach is best suited to the patient's specific tumor type. Chen added that his goal in all procedures is to destroy the tumor while maintaining the highest quality of life for his patients.

Patients undergoing thermal ablation are typically discharged from hospital one day after the procedure and can return to normal activities. The laser ablation requires real-time MRI monitoring and a dedicated intra-operative MRI team. The procedure cannot be performed in a conventional operating room.

The NeuroBlate System was developed by Monteris Medical, Inc., Plymouth, MN. The NeuroBlate System is also used to treat epileptic disorders and chronic inflammation caused by ionizing radiation.

Explore further: New minimally invasive, MRI-guided laser treatment for brain tumor found to be promising in study

Related Stories

New minimally invasive, MRI-guided laser treatment for brain tumor found to be promising in study

April 5, 2013
The first-in-human study of the NeuroBlate Thermal Therapy System finds that it appears to provide a new, safe and minimally invasive procedure for treating recurrent glioblastoma (GBM), a malignant type of brain tumor. The ...

Real-time MRI-guided gene therapy for brain cancer

August 7, 2013
Neurosurgeons at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center are among the first in the world to utilize real-time magnetic resonance imaging (MRI) guidance for delivery ...

Brain tumor removal through a hole smaller than a dime

November 4, 2013
More than two decades ago, Ryan Vincent had open brain surgery to remove a malignant brain tumor, resulting in a lengthy hospital stay and weeks of recovery at home. Recently, neurosurgeons at Houston Methodist Hospital removed ...

Brain surgeons go with the flow

November 22, 2013
(Medical Xpress)—Neurosurgeons at UC San Diego Health System are using a new approach to visualize the brain's delicate anatomy prior to surgery. The novel technique allows neurosurgeons to see the brain's nerve connections ...

Laser thermal therapy ends patient’s seizures

August 9, 2011
After suffering from uncontrollable epileptic seizures for more than 15 years, a new laser therapy has given a 48-year-old Houston-area woman a life without seizures.

Recommended for you

Researchers develop a remote-controlled cancer immunotherapy system

January 15, 2018
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.

Pancreatic tumors may require a one-two-three punch

January 15, 2018
One of the many difficult things about pancreatic cancer is that tumors are resistant to most treatments because of their unique density and cell composition. However, in a new Wilmot Cancer Institute study, scientists discovered ...

New immunotherapy approach boosts body's ability to destroy cancer cells

January 12, 2018
Few cancer treatments are generating more excitement these days than immunotherapy—drugs based on the principle that the immune system can be harnessed to detect and kill cancer cells, much in the same way that it goes ...

Cancer's gene-determined 'immune landscape' dictates progression of prostate tumors

January 12, 2018
The field of immunotherapy - the harnessing of patients' own immune systems to fend off cancer - is revolutionizing cancer treatment today. However, clinical trials often show marked improvements in only small subsets of ...

FDA approves first drug for tumors tied to breast cancer genes

January 12, 2018
(HealthDay)—The U.S. Food and Drug Administration on Friday approved the first drug aimed at treating metastatic breast cancers linked to the BRCA gene mutation.

Breast cancer gene does not boost risk of death: study

January 12, 2018
Young women with the BRCA gene mutation that prompted actress Angelina Jolie's pre-emptive and much-publicised double mastectomy are not more likely to die after a breast cancer diagnosis, scientists said Friday.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.